Tevogen Bio Holdings签署意向书 拟评估收购Sciometrix及其数字护理管理平台Clinicus

美股速递
Yesterday

Tevogen Bio Holdings已签署意向书,正就潜在收购医疗科技公司Sciometrix及其创新数字护理管理平台Clinicus展开评估。此次战略举措旨在整合Clinicus的智能化患者管理技术,强化Tevogen在精准医疗领域的数字化服务能力。

该平台通过人工智能驱动的远程监测系统,可实现个性化治疗方案的动态优化。若交易顺利完成,将显著提升Tevogen在细胞疗法商业化过程中的患者全周期管理效率。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10